GLUL and non-small cell lung carcinoma: Importantly, we showed here that GLUL ablation conferred drug resistance in A549 NSCLC cells, and that this resistance was supported mechanistically through modulation of glycolytic flux linked with an upregulation of malate-aspartate transport in mitochondria.